You are here

Dave Pearson
Senior Writer
Prior to joining TriMed in 2014, Dave was an independent reporter and copywriter. He has worked in journalism, public relations and marketing for more than 25 years, concentrating on business, healthcare, technology and religion. He has also worked extensively in fundraising communications, freelancing for local, national and international charities.
 - Ambulance5

In theory, having a mobile CT scanner available in a trauma resuscitation bay should save workup time over relying on a scanner near but not inside the bay. In reality, it doesn’t make a meaningful difference.

German scientists have developed a way to swap out contrast agents for a simple sugar solution to enhance brain cancer visualization on MRI.

 - ChildHospital

Gadolinium-based contrast agents (GBCAs) in the macrocyclic category have proven safe enough in children to be considered the standard of care across pediatrics whenever contrast-enhanced MR imaging is indicated, according the authors of a European study published online June 21 in Radiology.

 - ProstateC

A high proportion of prostate cancer patients have their care pathways changed after being scanned with PET/CT enhanced by the injected radiotracer gallium-68 (Ga-68) and prostate-specific membrane antigen (PSMA).

 - HowardU

First-year medical students at a historically black university in the nation’s capital are getting a deep introduction to the basics of radiology.

Migrating patient imaging data from one computer system to another demands attention to detail, as a healthcare system in Australia is learning in the wake of a mislabeling error affecting several hundred thousand medical images.

 - HeadMic

Implementing structured reporting templates has helped an academic radiology department increase its collective use of the clear and definitive term normal. However, use of the fuzzier term unremarkable also went up, suggesting more training may be in order.

 - NeuroCompare

Practical and noninvasive, MRI with arterial spin labeling may substitute for PET-CT with the radiotracer 18FDG, which requires intravenous injection, for imaging the brains of patients with suspected early-stage dementia.

 - Les_Jebson

U.S. healthcare is in for a wave of technology-driven disruption over the next five years unlike any it’s seen up to now—and it’s up to imaging professionals to light the way in figuring out what to embrace, what to reject and what to take a chance on.

The U.S. Department of Defense has given Fujifilm’s Synapse PACS the green light to operate on the department’s networks, granting the company an Authority to Operate (ATO) and making it the first medical-imaging vendor to obtain such clearance since DoD switched to its Risk Management Framework (RMF), according to a press release sent by Fujifilm Medical Systems USA.